Free Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome Case Study Solution | Assignment Help

Harvard Case - Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome

"Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome" Harvard business case study is written by David P. Baron. It deals with the challenges in the field of Business & Government Relations. The case study is 5 page(s) long and it was first published on : Oct 20, 2008

At Fern Fort University, we recommend that GlaxoSmithKline (GSK) adopt a multifaceted approach to address the ethical concerns surrounding its marketing of Restless Legs Syndrome (RLS) while maintaining its commitment to innovation and patient well-being. This approach should prioritize transparency, education, and responsible communication while navigating the complex landscape of business and government relations, government policy and regulation, and corporate social responsibility.

2. Background

This case study focuses on GlaxoSmithKline's (GSK) marketing strategy for Restless Legs Syndrome (RLS), a neurological disorder characterized by an irresistible urge to move the legs. GSK, a global pharmaceutical giant, launched Requip, a drug for RLS treatment, in 1998. However, its aggressive marketing tactics, including direct-to-consumer advertising and the creation of patient advocacy groups, raised concerns about 'disease mongering' ' the practice of expanding the boundaries of illness to create new markets for pharmaceutical products. This case study presents a critical analysis of GSK's actions, exploring the ethical implications of its marketing strategy and its impact on public perception of RLS.

The main protagonists of the case study are:

  • GlaxoSmithKline (GSK): A multinational pharmaceutical company that developed and marketed Requip for RLS treatment.
  • Patients with RLS: Individuals experiencing the symptoms of RLS who may be influenced by GSK's marketing efforts.
  • Medical professionals: Doctors and healthcare providers who prescribe medications for RLS and must navigate the information provided by GSK.
  • Regulators: Government agencies responsible for overseeing pharmaceutical marketing and ensuring patient safety.

3. Analysis of the Case Study

This case study can be analyzed through the lens of corporate social responsibility (CSR), marketing ethics, and government regulation.

CSR: GSK's actions raise questions about its responsibility to patients and society. While the company has a legitimate interest in promoting its products, its marketing practices may have contributed to the overdiagnosis and overtreatment of RLS, potentially leading to unnecessary side effects and costs.

Marketing Ethics: GSK's direct-to-consumer advertising and creation of patient advocacy groups raise concerns about the potential for manipulation and exploitation. By directly targeting patients, GSK may have influenced their perception of RLS and pressured them to seek treatment, even if it wasn't medically necessary.

Government Regulation: The case highlights the need for robust regulations to prevent pharmaceutical companies from engaging in unethical marketing practices. The FDA's role in regulating pharmaceutical advertising and the potential for increased oversight are critical aspects of this analysis.

Framework: Applying the Porter's Five Forces framework provides a comprehensive understanding of the competitive landscape:

  • Threat of New Entrants: High, as the pharmaceutical industry is characterized by ongoing innovation and the potential for new entrants with novel treatments.
  • Bargaining Power of Buyers: Moderate, as patients often rely on their healthcare providers for treatment recommendations, but they also have access to information and can influence treatment decisions.
  • Bargaining Power of Suppliers: Low, as pharmaceutical companies rely on a limited number of suppliers for raw materials and manufacturing.
  • Threat of Substitutes: Moderate, as alternative treatments for RLS exist, including lifestyle modifications and other medications.
  • Competitive Rivalry: High, as the pharmaceutical industry is highly competitive, with numerous companies vying for market share.

4. Recommendations

GSK should implement the following recommendations to address the ethical concerns surrounding its marketing of RLS:

  1. Transparency and Disclosure: GSK should be transparent about its marketing practices and the potential risks and benefits of Requip. This includes disclosing the financial relationships between GSK and patient advocacy groups and clearly stating the limitations of the drug's effectiveness.
  2. Education and Patient Empowerment: GSK should prioritize patient education about RLS and its treatment options. This includes providing accurate information about the condition, its diagnosis, and the potential risks and benefits of different treatments.
  3. Collaborative Approach with Healthcare Professionals: GSK should work closely with healthcare professionals to ensure that patients receive accurate and unbiased information about RLS. This could include providing educational materials and resources to doctors and encouraging open dialogue about treatment options.
  4. Responsible Marketing Practices: GSK should adopt responsible marketing practices that prioritize patient well-being over profit maximization. This includes limiting direct-to-consumer advertising, focusing on evidence-based information, and avoiding tactics that may mislead or pressure patients.
  5. Engagement with Regulators: GSK should proactively engage with regulatory bodies like the FDA to ensure its marketing practices comply with ethical guidelines and regulations. This includes actively participating in discussions about the regulation of pharmaceutical advertising and promoting responsible marketing practices within the industry.

5. Basis of Recommendations

These recommendations are based on the following considerations:

  1. Core Competencies and Consistency with Mission: GSK's core competency lies in pharmaceutical innovation and development. By adopting a more ethical and transparent approach to marketing, GSK can strengthen its reputation and maintain its commitment to patient well-being, aligning with its mission.
  2. External Customers and Internal Clients: These recommendations address the concerns of external customers (patients) and internal clients (healthcare professionals) by providing accurate information, promoting informed decision-making, and fostering trust.
  3. Competitors: By embracing ethical marketing practices, GSK can differentiate itself from competitors and gain a competitive advantage in the long run.
  4. Attractiveness: The recommendations are attractive as they contribute to a sustainable business model by fostering trust, reducing regulatory risks, and promoting long-term patient satisfaction.

6. Conclusion

GSK's marketing practices surrounding RLS raise significant ethical concerns. By adopting a more transparent, educational, and responsible approach, GSK can address these concerns, rebuild trust with patients and healthcare professionals, and maintain its position as a leading pharmaceutical company. This approach will ultimately contribute to a more ethical and sustainable pharmaceutical industry.

7. Discussion

Alternative approaches to addressing the ethical concerns include:

  • Complete withdrawal of Requip from the market: This would eliminate the ethical concerns but also forfeit potential revenue and deprive patients of a potentially beneficial treatment.
  • Stricter internal regulations: GSK could implement stricter internal guidelines for marketing practices, but this may not be sufficient to address the broader concerns about the industry.

Risks associated with the recommended approach include:

  • Increased regulatory scrutiny: GSK may face increased scrutiny from regulatory bodies if its marketing practices are perceived as unethical.
  • Negative public perception: GSK's reputation may be damaged if the public perceives its marketing practices as manipulative or exploitative.

Key assumptions:

  • GSK is committed to ethical business practices and patient well-being.
  • The recommendations are feasible and can be implemented effectively.
  • The pharmaceutical industry is willing to adopt more ethical marketing practices.

8. Next Steps

GSK should implement the recommendations outlined above in a phased approach:

  • Phase 1 (Immediate): Publicly commit to transparency and ethical marketing practices.
  • Phase 2 (Short-term): Develop and implement a comprehensive patient education program.
  • Phase 3 (Long-term): Engage with regulators and industry stakeholders to promote ethical marketing standards.

By taking these steps, GSK can address the ethical concerns surrounding its marketing of RLS and position itself as a responsible and ethical pharmaceutical leader.

Hire an expert to write custom solution for HBR Business Government case study - Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome

more similar case solutions ...

Case Description

In 2005, GlaxoSmithKline (GSK) received approval from the Food and Drug Administration (FDA) to market Requip (Ropinirole) for Restless Leg Syndrome. Requip had already been approved for the treatment of Parkinson's disease. Prior the FDA's approval, GSK had already undertaken an intensive promotional campaign for Requip, issuing press releases, advertising to doctors in medical journals, and advertising direct-to-consumer. In 2003 it began developing consumer awareness of RLS with an advertising campaign stating that a "new survey reveals a common yet underrecognized disorder-restless legs syndrome-is keeping Americans awake at night." While GSK explained that its campaign was simply raising awareness about RLS, others disagreed. GSK was accused of 'disease mongering,' or trying to turn normal people with ordinary experiences into patients. This case explores GSK's tactics and the distinction between raising awareness and inappropriately promoting a drug.

🎓 Struggling with term papers, essays, or Harvard case studies? Look no further! Fern Fort University offers top-quality, custom-written solutions tailored to your needs. Boost your grades and save time with expertly crafted content. Order now and experience academic excellence! 🌟📚 #MBA #HarvardCaseStudies #CustomEssays #AcademicSuccess #StudySmart Write my custom case study solution for Harvard HBR case - Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome

Hire an expert to write custom solution for HBR Business Government case study - Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome

Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome FAQ

What are the qualifications of the writers handling the "Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome" case study?

Our writers hold advanced degrees in their respective fields, including MBAs and PhDs from top universities. They have extensive experience in writing and analyzing complex case studies such as " Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome ", ensuring high-quality, academically rigorous solutions.

How do you ensure confidentiality and security in handling client information?

We prioritize confidentiality by using secure data encryption, access controls, and strict privacy policies. Apart from an email, we don't collect any information from the client. So there is almost zero risk of breach at our end. Our financial transactions are done by Paypal on their website so all your information is very secure.

What is Fern Fort Univeristy's process for quality control and proofreading in case study solutions?

The Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome case study solution undergoes a rigorous quality control process, including multiple rounds of proofreading and editing by experts. We ensure that the content is accurate, well-structured, and free from errors before delivery.

Where can I find free case studies solution for Harvard HBR Strategy Case Studies?

At Fern Fort University provides free case studies solutions for a variety of Harvard HBR case studies. The free solutions are written to build "Wikipedia of case studies on internet". Custom solution services are written based on specific requirements. If free solution helps you with your task then feel free to donate a cup of coffee.

I’m looking for Harvard Business Case Studies Solution for Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome. Where can I get it?

You can find the case study solution of the HBR case study "Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome" at Fern Fort University.

Can I Buy Case Study Solution for Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome & Seek Case Study Help at Fern Fort University?

Yes, you can order your custom case study solution for the Harvard business case - "Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome" at Fern Fort University. You can get a comprehensive solution tailored to your requirements.

Can I hire someone only to analyze my Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome solution? I have written it, and I want an expert to go through it.

🎓 Struggling with term papers, essays, or Harvard case studies? Look no further! Fern Fort University offers top-quality, custom-written solutions tailored to your needs. Boost your grades and save time with expertly crafted content. Order now and experience academic excellence! 🌟📚 #MBA #HarvardCaseStudies #CustomEssays #AcademicSuccess #StudySmart Pay an expert to write my HBR study solution for the case study - Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome

Where can I find a case analysis for Harvard Business School or HBR Cases?

You can find the case study solution of the HBR case study "Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome" at Fern Fort University.

Which are some of the all-time best Harvard Business Review Case Studies?

Some of our all time favorite case studies are -

Can I Pay Someone To Solve My Case Study - "Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome"?

Yes, you can pay experts at Fern Fort University to write a custom case study solution that meets all your professional and academic needs.

Do I have to upload case material for the case study Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome to buy a custom case study solution?

We recommend to upload your case study because Harvard HBR case studies are updated regularly. So for custom solutions it helps to refer to the same document. The uploading of specific case materials for Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome ensures that the custom solution is aligned precisely with your needs. This helps our experts to deliver the most accurate, latest, and relevant solution.

What is a Case Research Method? How can it be applied to the Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome case study?

The Case Research Method involves in-depth analysis of a situation, identifying key issues, and proposing strategic solutions. For "Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome" case study, this method would be applied by examining the case’s context, challenges, and opportunities to provide a robust solution that aligns with academic rigor.

"I’m Seeking Help with Case Studies,” How can Fern Fort University help me with my case study assignments?

Fern Fort University offers comprehensive case study solutions, including writing, analysis, and consulting services. Whether you need help with strategy formulation, problem-solving, or academic compliance, their experts are equipped to assist with your assignments.

Achieve academic excellence with Fern Fort University! 🌟 We offer custom essays, term papers, and Harvard HBR business case studies solutions crafted by top-tier experts. Experience tailored solutions, uncompromised quality, and timely delivery. Elevate your academic performance with our trusted and confidential services. Visit Fern Fort University today! #AcademicSuccess #CustomEssays #MBA #CaseStudies

How do you handle tight deadlines for case study solutions?

We are adept at managing tight deadlines by allocating sufficient human resources and prioritizing urgent projects. Our team works efficiently without compromising quality, ensuring that even last-minute requests are delivered on time

What if I need revisions or edits after receiving the case study solution?

We offer free revisions to ensure complete client satisfaction. If any adjustments are needed, our team will work closely with you to refine the solution until it meets your expectations.

How do you ensure that the case study solution is plagiarism-free?

All our case study solutions are crafted from scratch and thoroughly checked using advanced plagiarism detection software. We guarantee 100% originality in every solution delivered

How do you handle references and citations in the case study solutions?

We follow strict academic standards for references and citations, ensuring that all sources are properly credited according to the required citation style (APA, MLA, Chicago, etc.).

Hire an expert to write custom solution for HBR Business Government case study - Consumer Awareness or Disease Mongering? GlaxoSmithKline and the Restless Legs Syndrome



Most Read


Referrences & Bibliography for SWOT Analysis | SWOT Matrix | Strategic Management

1. Andrews, K. R. (1980). The concept of corporate strategy. Harvard Business Review, 61(3), 139-148.

2. Ansoff, H. I. (1957). Strategies for diversification. Harvard Business Review, 35(5), 113-124.

3. Brandenburger, A. M., & Nalebuff, B. J. (1995). The right game: Use game theory to shape strategy. Harvard Business Review, 73(4), 57-71.

4. Christensen, C. M., & Raynor, M. E. (2003). Why hard-nosed executives should care about management theory. Harvard Business Review, 81(9), 66-74.

5. Christensen, C. M., & Raynor, M. E. (2003). The innovator's solution: Creating and sustaining successful growth. Harvard Business Review Press.

6. D'Aveni, R. A. (1994). Hypercompetition: Managing the dynamics of strategic maneuvering. Harvard Business Review Press.

7. Ghemawat, P. (1991). Commitment: The dynamic of strategy. Harvard Business Review, 69(2), 78-91.

8. Ghemawat, P. (2002). Competition and business strategy in historical perspective. Business History Review, 76(1), 37-74.

9. Hamel, G., & Prahalad, C. K. (1990). The core competence of the corporation. Harvard Business Review, 68(3), 79-91.

10. Kaplan, R. S., & Norton, D. P. (1992). The balanced scorecard--measures that drive performance. Harvard Business Review, 70(1), 71-79.

11. Kim, W. C., & Mauborgne, R. (2004). Blue ocean strategy. Harvard Business Review, 82(10), 76-84.

12. Kotter, J. P. (1995). Leading change: Why transformation efforts fail. Harvard Business Review, 73(2), 59-67.

13. Mintzberg, H., Ahlstrand, B., & Lampel, J. (2008). Strategy safari: A guided tour through the wilds of strategic management. Harvard Business Press.

14. Porter, M. E. (1979). How competitive forces shape strategy. Harvard Business Review, 57(2), 137-145.

15. Porter, M. E. (1980). Competitive strategy: Techniques for analyzing industries and competitors. Simon and Schuster.

16. Porter, M. E. (1985). Competitive advantage: Creating and sustaining superior performance. Free Press.

17. Prahalad, C. K., & Hamel, G. (1990). The core competence of the corporation. Harvard Business Review, 68(3), 79-91.

18. Rumelt, R. P. (1979). Evaluation of strategy: Theory and models. Strategic Management Journal, 1(1), 107-126.

19. Rumelt, R. P. (1984). Towards a strategic theory of the firm. Competitive Strategic Management, 556-570.

20. Teece, D. J., Pisano, G., & Shuen, A. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509-533.